The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lenalidomide plus rituximab in patients with rituximab-resistant indolent B-cell and mantle cell lymphomas: 10-year follow-up.
 
Aditi Gupta
No Relationships to Disclose
 
Stephen J. Schuster
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Alimera Sciences; BeiGene; Celgene; Genentech/Roche; Juno Therapeutics; Loxo; Nordic Nanovector; Novartis; Tessa Therapeutics
Research Funding - Abbvie (Inst); Adaptive Biotechnologies (Inst); Celgene (Inst); DTRM (Inst); Genentech/Roche (Inst); Incyte (Inst); Juno Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent Combination Therapies of CAR and PD-1 Inhibitors (via University of Pennsylvania with royalties to Novartis)
 
Jakub Svoboda
Consulting or Advisory Role - Adaptive Biotechnologies; ADC Therapeutics; AstraZeneca; Atara Biotherapeutics; BMS; Genmab; Imbrium Therapeutics; Pharmacyclics; Seagen
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Imbrium Therapeutics
 
Sunita Nasta
Consulting or Advisory Role - Merck; MorphoSys
Research Funding - Aileron Therapeutics; Atara Biotherapeutics; Debiopharm Group; Forty Seven; Incyte; Millennium; Pharmacyclics/Janssen; Rafael Pharmaceuticals; Roche/Genentech
 
Ellen Napier
Travel, Accommodations, Expenses - Celgene; Novartis
(OPTIONAL) Uncompensated Relationships - Celgene
 
Kristy Walsh
No Relationships to Disclose
 
Elise A. Chong
Consulting or Advisory Role - Bristol-Myers Squibb; Kite, a Gilead company; Novartis; Tessa Therapeutics